Cargando…
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic
The development of a new lesion in a patient with a complete remission to anti-PD-1 therapy is highly concerning for a drug resistant escape lesion. Here, we present a case of a 62-year-old patient with chemotherapy-resistant metastatic urothelial cancer who had a complete remission to pembrolizumab...
Autores principales: | Melms, Johannes C., Thummalapalli, Rohit, Shaw, Kristin, Ye, Huihui, Tsai, Leo, Bhatt, Rupal S., Izar, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134551/ https://www.ncbi.nlm.nih.gov/pubmed/30208947 http://dx.doi.org/10.1186/s40425-018-0394-y |
Ejemplares similares
-
Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by
protein microarray
por: Wu, Min, et al.
Publicado: (2018) -
Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer
por: Sun, Wenhui, et al.
Publicado: (2017) -
Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP)
por: Dadfar, Seyed Mohammad Mahdi, et al.
Publicado: (2019) -
Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022) -
Hereditary Persistence of Alpha-Fetoprotein Is Associated with the −119G>A Polymorphism in AFP Gene
por: Deshpande, Neha, et al.
Publicado: (2017)